<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, curcumin shows very poor bioavailability, as many studies show very low, or even undetectable, blood and extraintestinal tissue concentrations. The key reasons given for this are its poor absorption, fast metabolism, chemical instability, and rapid systemic elimination [
 <xref rid="B79-plants-10-00063" ref-type="bibr">79</xref>]. Clinical phase I trials showed that curcumin is safe in humans, even at a dose of 12 g per day [
 <xref rid="B80-plants-10-00063" ref-type="bibr">80</xref>]. Numerous methods have been used to improve curcumin bioavailability. These methods include [
 <xref rid="B80-plants-10-00063" ref-type="bibr">80</xref>,
 <xref rid="B81-plants-10-00063" ref-type="bibr">81</xref>]: Use in combination with other compounds.
 <list list-type="order">
  <list-item>
   <p>Use as liposomal curcumin via liposomal technology.</p>
  </list-item>
  <list-item>
   <p>Curcumin as nanoparticles.</p>
  </list-item>
  <list-item>
   <p>Use as a curcuminâ€“phospholipid complex.</p>
  </list-item>
  <list-item>
   <p>New formulation (micelles, exosomes) to increase the bioavailability.</p>
  </list-item>
 </list>
</p>
